help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sun, Y.
Right arrow Articles by Gershengorn, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, Y.
Right arrow Articles by Gershengorn, M. C.
Endocrinology Vol. 143, No. 8 2886-2892
Copyright © 2002 by The Endocrine Society


ARTICLE

Correlation between Basal Signaling and Internalization of Thyrotropin-Releasing Hormone Receptors: Evidence for Involvement of Similar Receptor Conformations

Yuhua Sun and Marvin C. Gershengorn

The Division of Molecular Medicine, Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021; and the Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-8029

Address all correspondence and requests for reprints to: Marvin C. Gershengorn, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 50 South Drive, MSC 8029, Bethesda, Maryland 20892-8029. E-mail: . marving{at}intra.niddk.nih.gov

Previous studies have shown that rat thyrotropin-releasing hormone (TRH) receptor type 2 exhibits higher basal signaling activity and internalizes more rapidly upon agonist binding than rat TRH receptor type 1. The mouse TRH receptor type 2 (mR2) was recently cloned and, similar to its rat homolog, shows a higher basal signaling activity than mR1. Taking advantage of the high degree of sequence homology between mR1 and mR2, we used chimeras/mutants of these receptors to gain insight into the properties of the receptors that influence internalization and basal signaling. Chimeric receptors that have the mR1 extracellular and transmembrane domains with the carboxyl terminus and intracellular loops of mR2 (R1/R2-tail; R1/R2-I3,tail; R1/R2-I2,3,tail; R1/R2-I1,2,3,tail) exhibited internalization rates and basal activities that were similar to that of mR1. In contrast, a chimeric receptor with the extracellular and transmembrane domains of mR2 and the carboxyl terminus of mR1 exhibited the more rapid internalization rate and higher basal signaling activity characteristic of mR2. We showed previously that mutation of a highly conserved tryptophan to alanine caused mR1 to exhibit a high basal signaling activity and rapid internalization rate. In contrast, mutation of this tryptophan to alanine in mR2 decreased the rate of internalization and inhibited basal signaling activity. The rates of receptor internalization did not correlate with the binding affinities, coupling efficiencies, or potencies of the receptors. Thus, we observed that receptors with more rapid internalization rates showed relatively higher basal signaling activities, whereas receptors with lower basal signaling activities showed slower internalization rates. These data suggest that similar receptor conformations are required for productive coupling to signaling G proteins and to proteins involved in internalization.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Engel, S. Neumann, N. Kaur, V. Monga, R. Jain, J. Northup, and M. C. Gershengorn
Low Affinity Analogs of Thyrotropin-releasing Hormone Are Super-agonists
J. Biol. Chem., May 12, 2006; 281(19): 13103 - 13109.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. Du, B. M. Raaka, H. Grimberg, M. Lupu-Meiri, Y. Oron, and M. C. Gershengorn
Carboxyl Tail Cysteine Mutants of the Thyrotropin-Releasing Hormone Receptor Type 1 Exhibit Constitutive Signaling: Role of Palmitoylation
Mol. Pharmacol., July 1, 2005; 68(1): 204 - 209.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
X. Lu, W. Huang, S. Worthington, P. Drabik, R. Osman, and M. C. Gershengorn
A Model of Inverse Agonist Action at Thyrotropin-Releasing Hormone Receptor Type 1: Role of a Conserved Tryptophan in Helix 6
Mol. Pharmacol., November 1, 2004; 66(5): 1192 - 1200.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. C. Hanyaloglu, R. M. Seeber, T. A. Kohout, R. J. Lefkowitz, and K. A. Eidne
Homo- and Hetero-oligomerization of Thyrotropin-releasing Hormone (TRH) Receptor Subtypes. DIFFERENTIAL REGULATION OF beta -ARRESTINS 1 AND 2
J. Biol. Chem., December 20, 2002; 277(52): 50422 - 50430.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society